Advertisements


Allogene Therapeutics Files for IPO

Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering......»»

Category: blogSource: 247wallstSep 14th, 2018

Sorrento Therapeutics files to sell 1.33M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall9 hr. 13 min. ago

Marker Therapeutics files $200M mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

Seres Therapeutics files to sell $60M in common stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2019

Soleno Therapeutics files to sell $100M of common stock, warrants

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2019

Stoke Therapeutics Files Proposed Terms For IPO

Stoke Therapeutics Files Proposed Terms For IPO.....»»

Category: topSource: seekingalphaJun 11th, 2019

Chandler opioid maker files for bankruptcy protection

A troubled Chandler-based pharmaceutical firm that has been at the center of ongoing lawsuits and other action related to the national opioid epidemic has filed for bankruptcy protection. In a regulatory filing Monday, Insys Therapeutics (Nasdaq: .....»»

Category: topSource: bizjournalsJun 10th, 2019

Opioid manufacturer Insys files for bankruptcy after kickback probe

Drugmaker Insys Therapeutics Inc filed for bankruptcy protection on Monday amid mounting expenses driven by a U.S. Justice Department probe into claims it paid doctors bribes to prescribe a powerful opioid medication......»»

Category: topSource: reutersJun 10th, 2019

Opioid maker Insys Therapeutics files Chapter 11 bankruptcy after corruption charges

Pharmaceutical company Insys Therapeutics filed for Chapter 11 bankruptcy protection Monday less than a week after pleading .....»»

Category: topSource: usatodayJun 10th, 2019

The Wall Street Journal: Insys files for Chapter 11 days after settling opioid case

Specialty-pharmaceutical company Insys Therapeutics Inc. filed for chapter 11 bankruptcy with plans to sell its assets, just days after agreeing to pay $225 million to settle federal charges over sales of its opioid drug Subsys......»»

Category: topSource: marketwatchJun 10th, 2019

Opioid drugmaker Insys Therapeutics files for bankruptcy

Opioid drugmaker Insys Therapeutics files for bankruptcy.....»»

Category: topSource: foxnewsJun 10th, 2019

Insys files for bankruptcy, stock plunges toward record low

Shares of Insys Therapeutics Inc. plunged 68% toward a record low in premarket trade Monday, after.....»»

Category: topSource: marketwatchJun 10th, 2019

Opioid drugmaker Insys Therapeutics files for bankruptcy

Drugmaker Insys Therapeutics Inc filed for Chapter 11 bankruptcy protection on Monday, about a week after agreeing to pay $225 million to settle a U.S. probe into bribes it paid to doctors for prescribing a powerful opioid medication......»»

Category: topSource: reutersJun 10th, 2019

Novus Therapeutics files to sell 7.07M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 7th, 2019

Enlivex Therapeutics files $100M mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 7th, 2019

Allogene Therapeutics (ALLO) Investor Presentation - Slideshow

Allogene Therapeutics (ALLO) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaJun 6th, 2019

Allogene Therapeutics initiated with a Neutral at Roth Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2019

Allogene Therapeutics announces FDA clearance of ALLO-715 IND

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2019

Outlook Therapeutics files $100M mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2019

Schizophrenia biotech Karuna Therapeutics files for a $75 million IPO

Karuna Therapeutics a Phas.....»»

Category: futuresSource: nasdaqJun 1st, 2019

Allogene Therapeutics initiated with a Hold at Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2019